UzielYHashkesPJ.Growing pains in children [in Hebrew]. Harefuah. 2008;147:809-811, 836.
2.
HarelL.Growing pains: myth or reality. Pediatr Endocrinol Rev. 2010;8:76-78.
3.
WeiserP.Approach to the patient with noninflammatory musculoskeletal pain. Pediatr Clin North Am. 2012;59:471-492.
4.
LoweRMHashkesPJ.Growing pains: a noninflammatory pain syndrome of early childhood. Nat Clin Pract Rheumatol. 2008;4:542-549.
5.
EvansAMScutterSD.Prevalence of “growing pains” in young children. J Pediatr. 2004;145:255-258.
6.
MitchellSMonsellF.Growing pains: making an accurate diagnosis. Practitioner. 2006;250:28, 31-32, 34.
7.
FriedlandOHashkesPJJaberLet al. Decreased bone strength in children with growing pains as measured by quantitative ultrasound. J Rheumatol. 2005;32:1354-1357.
GintyFFlynnACashmanK.The effect of dietary sodium intake on biochemical markers of bone metabolism in young women. Br J Nutr. 1998;79:343-350.
10.
WheaterGElshahalyMTuckSPDuttaHKvan LaarJM.The clinical utility of bone marker measurements in osteoporosis. J Trans Med. 2013;11:201.
11.
WuXYLiHLXieHet al. Age-related bone turnover markers and osteoporotic risk in native Chinese women. BMC Endocr Disord. 2014;14:8.
12.
TerreniAPezzatiP.Biochemical markers in the follow-up of the osteoporotic patients. Clin Cases Miner Bone Metab. 2012;9:80-84.
13.
PisaniPRennaMDConversanoFet al. Screening and early diagnosis of osteoporosis through X-ray and ultrasound based techniques. World J Radiol. 2013;5:398-410.
ToporLSMelvinPGiancaterinoCGordonCM.Factors associated with low bone density in patients referred for assessment of bone health. Int J Pediatr Endocrinol. 2013;2013:4.
16.
NjehCFSamatSBNightingaleAMc NeilEABoivinCM.Radiation dose and in vitro precision in paediatric bone mineral density measurement using dual X-ray absorptiometry. Br J Radiol. 1997;70:719-727.
17.
BlakeGMNaeemMBoutrosM.Comparison of effective dose to children and adults from dual X-ray absorptiometry examination. Bone. 2006;38:935-942.
18.
BaroncelliGI.Quantitative ultrasound methods to assess bone mineral status in children: technical characteristics, performance, and clinical application. Pediatr Res. 2008;63:220-228.
19.
MerglerSLöbkerBEvenhuisHMPenningC.Feasibility of quantitative ultrasound measurement of the heel bone in people with intellectual disabilities. Res Dev Disabil. 2010;31:1283-1290.
20.
BeerhorstKTanJTanIYVerschuurePAldenkampAP.Dual-energy X-ray absorptiometry versus quantitative ultrasonography in diagnosing osteoporosis in patients with refractory epilepsy and chronic antiepileptic drug use. Ther Adv Musculoskelet Dis. 2013;5:59-66.
21.
KrahenbühlTGonçalvesEMCostaETAdeBFA. Factors that influence bone mass of healthy children and adolescents measured by quantitative ultrasound at the hand phalanges: a systematic review [in Portuguese]. Rev Paul Pediatr. 2014;32:266-272.
22.
SrichanWThasanasuwanWKijboonchooKRojroongwasinkulNWimonpeerapattanaWKhouwI.Bone status measured by quantitative ultrasound: a comparison with DXA in Thai children. Eur J Clin Nutr. 2016;70:894-897.
23.
EvansAMScutterSDLangLDansieB.“Growing pains” in young children: a study of the profile, experiences and quality of life issues of four to six year old children with recurrent leg pain. Foot. 2006;16:120-124.
24.
HashkesPFriedlandOJaberLCohenAWolachBUzielY.Children with growing pains have decreased pain threshold. J Rheumatol. 2004;31:610-613.
25.
EvansAMScutterSD.Are foot posture and functional health different in children with growing pains?Pediatr Int. 2007;49:991-996.
26.
NaishJMApleyJ.“Growing pains”: a clinical study of non-arthritic limb pains in children. Arch Dis Child. 1951;26:134-140.
27.
UzielYChapnickGJaberLNemetDHashkesPJ.Five-year outcome of children with “growing pains”: correlations with pain threshold. J Pediatr. 2010;156:838-840.
28.
BishopJLNorthstoneKEmmettPMGoldingJ.Parental accounts of the prevalence, causes and treatments of limb pain in children aged 5 to 13 years: a longitudinal cohort study. Arch Dis Child. 2012;97:52-53.
29.
SayersAFraserWDLawlorDATobiasJH.25-Hydroxyvitamin-D3 levels are positively related to subsequent cortical bone development in childhood: findings from a large prospective cohort study. Osteoporos Int. 2012;23:2117-2128.
30.
LeeJYSoTYThackrayJ.A review on vitamin D deficiency treatment in pediatric patients. J Pediatr Pharmacol Ther. 2013;18:277-291.
31.
ChengSTylavskyFKrögerHet al. Association of low 25-hydroxyvitamin D concentrations with elevated parathyroid hormone concentrations and low cortical bone density in early pubertal and prepubertal Finnish girls. Am J Clin Nutr. 2003;78:485-492.
32.
LawlorDAWillsAKFraserASayersAFraserWDTobiasJH.Association of maternal vitamin D status during pregnancy with bone-mineral content in offspring: a prospective cohort study. Lancet. 2013;22;381:2176-2183.
33.
HarveyNCSheppardAGodfreyKMet al. Childhood bone mineral content is associated with methylation status of the RXRA promoter at birth. J Bone Miner Res. 2014;29:600-607.
34.
HanSWKangHRKimHGKimJHUhmJHSeoJY.Subclinical vitamin D insufficiency in Korean school-aged children. Pediatr Gastroenterol Hepatol Nutr. 2013;16:254-260.
35.
PelaI.How much vitamin D for children?Clin Cases Miner Bone Metab. 2012;9:112-117.
36.
MohantaMP.Growing pains: practitioners’ dilemma. Indian Pediatr. 2014;51:379-383.
37.
MorandiGMainesEPionaCet al. Significant association among growing pains, vitamin D supplementation, and bone mineral status: results from a pilot cohort study. J Bone Miner Metab. 2015;33:201-206.
38.
PomerantsTTillmannVJürimäeJJürimäeT.The influence of serum ghrelin, IGF axis and testosterone on bone mineral density in boys at different stages of sexual maturity. J Bone Miner Metab. 2007;25:193-197.
39.
ElisSCourtlandHWWuYet al. Elevated serum levels of IGF-1 are sufficient to establish normal body size and skeletal properties even in the absence of tissue IGF-1. J Bone Miner Res. 2010;25:1257-1266.
40.
SolimanATAl KhalafFAlhemaidiNAl AliMAl ZyoudMYakootK.Linear growth in relation to the circulating concentrations of insulin-like growth factor I, parathyroid hormone, and 25-hydroxy vitamin D in children with nutritional rickets before and after treatment: endocrine adaptation to vitamin D deficiency. Metabolism. 2008;57:95-102.
41.
EdouardTGrünenwaldSGenneroISallesJPTauberM.Prevalence of IGF-1 deficiency in prepubertal children with isolated short stature. Eur J Endocrinol. 2009;161:43-50.
42.
BreenMELaingEMHallDBHausmanDBTaylorRGIsalesCMet al. 25-hydroxyvitamin D, insulin-like growth factor-I, and bone mineral accrual during growth. J Clin Endocrinol Metab. 2011;96:E89-E98.
43.
KumarVVenkatasubramanianG.Gabapentin treatment in clozapine-induced restless legs syndrome: two cases and a review of the literature. Ther Adv Psychopharmacol. 2017;7:42-47.
44.
WinkelmanJWGagnonAClairAG.Sensory symptoms in restless legs syndrome: the enigma of pain. Sleep Med. 2013;14:934-942.
45.
FoxGN.Restless legs syndrome. Am Fam Physician. 1986;33:147-152.
46.
GuptaRLahanVGoelD.Restless legs syndrome: a common disorder, but rarely diagnosed and barely treated—an Indian experience. Sleep Med. 2012;13:838-841.
47.
ComellaCL.Treatment of restless legs syndrome. Neurotherapeutics. 2014;11:177-187.
48.
BenbirGGuilleminaultC.Pramipexole: new use for an old drug—the potential use of pramipexole in the treatment of restless legs syndrome. Neuropsychiatr Dis Treat. 2006;2:393-405.
49.
MarelliSGalbiatiARinaldiFet al. Restless legs syndrome/Willis Ekbom disease: new diagnostic criteria according to different nosology. Arch Ital Biol. 2015;153:184-193.
